99¢ of every dollar received goes to fund cancer research
Cervical Cancer
Targeting Hormonal Triggers in Cervical Cancer
Lois Ramondetta, MD
MD Anderson Cancer Center
Clinical Title: Targeting Stress Factors in Women with Advanced and /or Recurrent Cervical Cancer. Phase II study
Clinical Description:
The stress hormone noradrenaline fuels the growth and spread of aggressive malignant tumors. Previous studies suggest a new and potentially life-saving role for beta blockers, drugs commonly used to treat heart arrhythmias and high blood pressure. Beta blockers reverse the effects of noradrenaline. It is hypothesized that the use of a beta blocker propanolol and relaxation intervention down regulate the effects of neurobiological stressors in patients with advanced cervical cancer and thereby increase overall survival and progression free survival.
Status: Active Trial
Accepting Patients? No
DONATE to support Cervical Cancer Research »
« Back to Funded Clinical Trials
CANCER FACTS:
1,500 American people died today from cancer.
1,500 more will die tomorrow and the next day and the next...
Demanding it all!
Funding innovative cancer research for
Treatments. Cures. Life.